cyclopentane has been researched along with Leukemia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhattacharjee, RN; da Silva, SR; Dhe-Paganon, S; Goard, CA; Gunning, PT; Hurren, R; Lukkarila, JL; Maclean, N; Medeiros, B; Paiva, SL; Petroski, MD; Schimmer, AD; Sukhai, MA; Toth, JI; Xu, GW | 1 |
Hong, JH; Kim, S | 1 |
Akimoto, M; Honma, Y; Ishii, Y; Ishikura, H; Kiyota, H; Tsumura, H | 1 |
Chiaro, C; Gandhi, UH; Hafer, KT; Hankey, P; Hegde, S; Kaushal, N; Kennett, MJ; Paulson, RF; Prabhu, KS; Ravindra, KC; Thompson, JT; van den Heuvel, JP | 1 |
Bascans, E; Belloc, F; Bernard, P; Bilhou-Nabera, C; Boisseau, MR; Bonnefille, S; Labroille, G; Lacombe, F | 1 |
Fontenelle, LJ; Henderson, JF; Lalanne, M; Smith, CM | 1 |
6 other study(ies) available for cyclopentane and Leukemia
Article | Year |
---|---|
Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Cell Line, Tumor; Cullin Proteins; Cyclopentanes; DNA Mutational Analysis; Drug Resistance, Neoplasm; Enzyme Inhibitors; Genotype; Humans; K562 Cells; Leukemia; Models, Molecular; NEDD8 Protein; Point Mutation; Protein Binding; Protein Conformation; Pyrimidines; Structure-Activity Relationship; U937 Cells; Ubiquitin-Activating Enzymes; Ubiquitins | 2014 |
Synthesis of Novel 4'-Trifluoromethyl-5'-Norcarbocyclic C-Nucleoside Phosphonic Acids as Potent Anti-Leukemic Agents.
Topics: Animals; Anti-HIV Agents; Cell Line, Tumor; Cyclopentanes; HIV-1; Humans; Leukemia; Mice; Molecular Structure; Nucleosides; Phosphorous Acids | 2015 |
Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture.
Topics: Acetates; Cell Differentiation; Cyclopentanes; Cytokinins; Esters; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; HL-60 Cells; Humans; Isopentenyladenosine; Leukemia; Oxylipins; Tumor Cells, Cultured | 2009 |
Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Survival; Cyclopentanes; DNA-Binding Proteins; Dose-Response Relationship, Drug; Fatty Acids, Omega-3; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Structure; Neoplastic Stem Cells; Prostaglandins; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Splenomegaly; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2011 |
Cytometric study of intracellular P-gp expression and reversal of drug resistance.
Topics: Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Brefeldin A; Cell Division; Cycloheximide; Cyclopentanes; Cytoplasm; DNA Primers; Drug Resistance, Multiple; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Kinetics; Leukemia; Macrolides; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-abl; RNA, Messenger; Transfection; Tumor Cells, Cultured | 1998 |
Inhibition of purine ribonucleotide and phosphoribosyl pyrophosphate synthesis by 6-cyclopentylthio-9-hydroxymethylpurine and structurally related compounds.
Topics: Adenine; Animals; Carbon Radioisotopes; Carcinoma, Ehrlich Tumor; Cell Line; Cells, Cultured; Cyclopentanes; Guanine; Hypoxanthines; Leukemia; Organophosphorus Compounds; Pentosephosphates; Phosphoric Acids; Purine Nucleotides; Purines; Ribonucleotides | 1974 |